Amy Burrell
About Amy Burrell
Amy Burrell is a Process Development Technician at Sangamo Therapeutics, Inc. in Valbonne, France, where she has worked since 2022, focusing on CAR-Tregs manufacturing processes and compliance with GMP standards.
Work at Sangamo Therapeutics
Amy Burrell has been employed as a Process Development Technician at Sangamo Therapeutics, Inc. since 2022. She works in Valbonne, Provence-Alpes-Côte d'Azur, France, where she contributes to the development of CAR-Tregs manufacturing processes for the company's immunology programs. In her role, she ensures compliance with Good Manufacturing Practice (GMP) standards and is involved in the testing and evaluation of new protocols and technologies.
Education and Expertise
Amy Burrell holds a Bachelor of Science (Honours) in Biomedical Science from The University of Queensland, where she studied from 2015 to 2017. Her educational background includes a scholarship at Ludwig-Maximilians-Universität München, where she served as an Honours Student for nine months in 2019. This academic experience has equipped her with a solid foundation in biomedical science, contributing to her expertise in process development and laboratory management.
Background
Before joining Sangamo Therapeutics, Amy Burrell held several positions in research and laboratory management. She worked as a Research Assistant at the UQ Institute for Molecular Bioscience from 2018 to 2019 and served as a Research Technician and Laboratory Manager at the Technical University of Munich from 2020 to 2021. These roles provided her with extensive experience in scientific research and laboratory operations.
Professional Experience
Amy Burrell's professional experience includes a range of roles in the biomedical field. She worked as a Research Technician and Laboratory Manager at the Technical University of Munich for one year, where she gained valuable skills in laboratory management. Additionally, her role as a Research Assistant at the UQ Institute for Molecular Bioscience further developed her research capabilities, contributing to her current position at Sangamo Therapeutics.